BRAF-V600E-Testung beim metastasierten kolorektalen Karzinom und neue, chemotherapiefreie Therapieoptionen

In the past 25 years, treatment of metastatic colorectal cancer (mCRC) has undergone profound changes. The approval of newer chemotherapeutics such as irinotecan and oxaliplatin was followed in 2005 by the first targeted therapies, for example, monoclonal antibodies directed against the epidermal gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hummel, Michael, Hegewisch-Becker, Susanna, Neumann, Jens, Vogel, Arndt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Übersichten
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536591/
https://www.ncbi.nlm.nih.gov/pubmed/33956173
http://dx.doi.org/10.1007/s00292-021-00942-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536591/
https://www.ncbi.nlm.nih.gov/pubmed/33956173
http://dx.doi.org/10.1007/s00292-021-00942-9

Ejemplares similares